search

Active clinical trials for "Arrhythmias, Cardiac"

Results 51-60 of 689

Monitoring of Arrhythmias in Patients Treated With Antipsychotics

DeathSudden3 more

Antipsychotics may be associated to life-threatening arrhythmias and sudden cardiac death. This is the fist study to estimated the arrhythmic burden using long-term monitoring by implantable loop recorder in patients treated with antipsychotics.

Recruiting15 enrollment criteria

The Collection and Transmission of Electrocardiogram Using a Wearable Device

Arrhythmia

A multi-center clinical trial to explore the status of collection and transmission of electrocardiogram using a wearable device

Recruiting4 enrollment criteria

Skin Sympathetic Nerve Activity and Cardiac Arrhythmia

Sudden DeathVentricular Tachycardia1 more

Sympathetic tone is important in cardiac arrhythmogenesis. The simultaneous recording of sympathetic nerve activity (SNA) and electrocardiogram (ECG) was obtained by invasive method. The purpose of this protocol is to further develop this recording method to turn it into a new non-invasive tool for arrhythmia prediction and detection. This method may also be useful in validating the results of surgical procedures aimed at sympathetic denervation

Recruiting4 enrollment criteria

Early Diagnosis of Atrial Fibrillation in the Wait-Time Prior to Seeing a Cardiologist

Atrial FibrillationAtrial Fibrillation Paroxysmal3 more

A randomized patient-oriented trial to investigate whether continual symptomatic use of the Kardia Mobile monitoring device is a superior strategy for diagnosing Atrial Fibrillation (AF) in comparison to normal ambulatory monitoring with a 24-hour Holter monitor. Patients with referrals to an Electrophysiologist, symptoms of AF but no documentation of AF, and with at least one stroke risk factor based on the CHADS2 scoring system are randomized 1:1 to Kardia Mobile monitoring versus Holter monitoring alone.

Recruiting6 enrollment criteria

Beat to Beat A Study in Paediatric, Adolescent and Young Adult Patients Who Are Undergoing or Have...

NeoplasmsCardiac Arrhythmia

A prospective study in paediatric, adolescent and young adult patients aged 7 to 18 years to evaluate the agreement between QTc measured using 12 lead electrocardiogram (ECG) and the wearable device ECG.

Recruiting12 enrollment criteria

Autoimmune Basis for Postural Tachycardia Syndrome

Postural Orthostatic Tachycardia SyndromePostural Tachycardia Syndrome7 more

The purpose of this study is to see if some people with postural tachycardia syndrome (POTS) have higher levels of immune proteins (autoantibodies) directed against receptors of the autonomic nervous system, and if these autoantibodies make a difference in their POTS symptoms. The investigators also want to see if the levels of these autoantibodies stay the same over time.

Enrolling by invitation19 enrollment criteria

Comparison of PFA vs. RFA in Patients With Symptomatic Paroxysmal Atrial Fibrillation.

ArrhythmiasCardiac1 more

This study is a mulitcentre, randomized, parallel-group evaluation of pulse field ablation(PFA) and radiofrequency ablation(RFA) in patients being treated for symptomatic paroxysmal AF. Pulmonary-vein isolation (PVI) is the primary intention of catheter ablation in both groups.

Not yet recruiting22 enrollment criteria

AI-powered ECG Analysis Using Willem™ Software in High-risk Cardiac Patients (WILLEM)

CardiomyopathiesCardiac Arrest2 more

WILLEM is a multi-center, prospective and retrospective cohort study. The study will assess the performance of a cloud-based and AI-powered ECG analysis platform, named Willem™, developed to detect arrhythmias and other abnormal cardiac patterns. The main questions it aims to answer are: A new AI-powered ECG analysis platform can automatice the classification and prediction of cardiac arrhythmic episodes at a cardiologist level. This AI-powered ECG analysis can delay or even avoid harmful therapies and severe cardiac adverse events such as sudden death. The prerequisites for inclusion of patients will be the availability of at least one ECG record in raw data, along with patient clinical data and evolution data after more than 1-year follow-up. Cardiac electrical signals from multiple medical devices will be collected by cardiology experts after obtaining the informed consent. Every cardiac electrical signal from every subject will be reviewed by a board-certified cardiologist to label the arrhythmias and patterns recorded in those tracings. In order to obtain tracings of relevant information, >95% of the subjects enrolled will have rhythm disorders or abnormal ECG's patterns at the time of enrollment.

Recruiting6 enrollment criteria

Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic...

Atrial FibrillationAtrial Fibrillation10 more

Demonstrate the safety and effectiveness of the Ablacath™ Mapping Catheter and Ablamap® System in patients with all types of atrial fibrillation (AF) including paroxysmal or persistent or long-standing persistent, undergoing and De Novo or Redo procedures. Phenotype patients and demonstrate the prognostication power of Electrographic Flow (EGF®) maps among all subjects using 12-month follow-up outcomes following EGF-guided mapping and ablation.

Not yet recruiting14 enrollment criteria

Evaluation of an Innovative Smart T-shirt Capable to Monitor ECG Signal and Related Parameters Through...

Cardiac Arrhythmias

Evaluation of an innovative smart t-shirt capable to monitor ECG signal and related parameters through the comparison with a Holter ECG and a smartwatch

Recruiting8 enrollment criteria
1...567...69

Need Help? Contact our team!


We'll reach out to this number within 24 hrs